42 Pharmaceutical drug development services in relation to the following diseases-- asthma, chronic obstructive pulmonary disease, lung cancer, lung infections, pulmonary arterial hypertension, arrhythmias and pain management for the foregoing; pharmaceutical research services, namely, analytical and in vitro method development, formulation development and validation services in relation to the following diseases-- asthma, chronic obstructive pulmonary disease, lung cancer, lung infections, pulmonary arterial hypertension, arrhythmias and pain management for the foregoing; pharmaceutical drug testing services in relation to the following diseases-- asthma, chronic obstructive pulmonary disease, lung cancer, lung infections, pulmonary arterial hypertension, arrhythmias and pain management for the foregoing